Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure

Author:

Tamaki Yodo1ORCID,Yaku Hidenori2,Morimoto Takeshi3ORCID,Inuzuka Yasutaka4,Ozasa Neiko5,Yamamoto Erika5,Yoshikawa Yusuke5ORCID,Miyake Makoto1ORCID,Kondo Hirokazu1,Tamura Toshihiro1,Kitai Takeshi6,Iguchi Moritake7ORCID,Nagao Kazuya8,Nishikawa Ryusuke9,Kawase Yuichi10,Morinaga Takashi11,Kawato Mitsunori12,Toyofuku Mamoru13,Sato Yukihito14,Kuwahara Koichiro15ORCID,Nakagawa Yoshihisa16,Kato Takao5ORCID,Kimura Takeshi5,

Affiliation:

1. Department of Cardiology Tenri Hospital Nara Japan

2. Department of Cardiology Mitsubishi Kyoto Hospital Kyoto Japan

3. Department of Clinical Epidemiology Hyogo College of Medicine Hyogo Japan

4. Department of Cardiovascular Medicine Shiga General Hospital Shiga Japan

5. Department of Cardiovascular Medicine Kyoto University Graduate School of Medicine Kyoto Japan

6. Department of Cardiovascular Medicine Kobe City Medical Center General Hospital Hyogo Japan

7. Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan

8. Cardiovascular Center Osaka Red Cross Hospital Osaka Japan

9. Department of Cardiology Shizuoka General Hospital Shizuoka Japan

10. Department of Cardiovascular Medicine Kurashiki Central Hospital Okayama Japan

11. Department of Cardiology Kokura Memorial Hospital Fukuoka Japan

12. Department of Cardiology Nishikobe Medical Center Hyogo Japan

13. Department of Cardiology Japanese Red Cross Wakayama Medical Center Wakayama Japan

14. Department of Cardiology Hyogo Prefectural Amagasaki General Medical Center Hyogo Japan

15. Department of Cardiovascular Medicine Shinshu University Nagano Japan

16. Division of Cardiovascular Medicine Shiga University of Medical Science Shiga Japan

Abstract

Background It remains unclear whether beta‐blocker use at hospital admission is associated with better in‐hospital outcomes in patients with acute decompensated heart failure. Methods and Results We evaluated the factors independently associated with beta‐blocker use at admission, and the effect of beta‐blocker use at admission on in‐hospital mortality in 3817 patients with acute decompensated heart failure enrolled in the Kyoto Congestive Heart Failure registry. There were 1512 patients (39.7%) receiving, and 2305 patients (60.3%) not receiving beta‐blockers at admission for the index acute decompensated heart failure hospitalization. Factors independently associated with beta‐blocker use at admission were previous heart failure hospitalization, history of myocardial infarction, atrial fibrillation, cardiomyopathy, and estimated glomerular filtration rate <30 mL/min per 1.73 m 2 . Factors independently associated with no beta‐blocker use were asthma, chronic obstructive pulmonary disease, lower body mass index, dementia, older age, and left ventricular ejection fraction <40%. Patients on beta‐blockers had significantly lower in‐hospital mortality rates (4.4% versus 7.6%, P <0.001). Even after adjusting for confounders, beta‐blocker use at admission remained significantly associated with lower in‐hospital mortality risk (odds ratio, 0.41; 95% CI, 0.27–0.60, P <0.001). Furthermore, beta‐blocker use at admission was significantly associated with both lower cardiovascular mortality risk and lower noncardiovascular mortality risk. The association of beta‐blocker use with lower in‐hospital mortality risk was relatively more prominent in patients receiving high dose beta‐blockers. The magnitude of the effect of beta‐blocker use was greater in patients with previous heart failure hospitalization than in patients without ( P for interaction 0.04). Conclusions Beta‐blocker use at admission was associated with lower in‐hospital mortality in patients with acute decompensated heart failure. Registration URL: https://www.upload.umin.ac.jp/ ; Unique identifier: UMIN000015238.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3